Home › Funds › BAR HARBOR WEALTH MANAGEMENT › ABT

BAR HARBOR WEALTH MANAGEMENT position in ABT

ABBOTT LABORATORIES · Health Care

BAR HARBOR WEALTH MANAGEMENT reported holding 147,465 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$14.6M, representing 0.80% of its reported portfolio and ranking #29 among its reported holdings. BAR HARBOR WEALTH MANAGEMENT has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)147.47K sh
Reported value held$14.57M
Portfolio Weight0.80%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BAR HARBOR WEALTH MANAGEMENT's ABT position evolved

BAR HARBOR WEALTH MANAGEMENT first disclosed a stake in ABT in Q3 2023 at 143,850 shares (US$13.9M). The position peaked in Q2 2025 at 137,655 shares, worth US$18.7M. Across 13 filings, BAR HARBOR WEALTH MANAGEMENT increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 147,465 shares valued at US$14.6M — an increase of 4,201 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 143.85K $13.93M New
Q4 2023 142.35K $15.67M Reduce
Q1 2024 142.56K $16.20M Hold
Q2 2024 141.40K $14.69M Reduce
Q3 2024 139.22K $15.87M Reduce
Q4 2024 140.79K $15.92M Add
Q1 2025 139.71K $18.53M Reduce
Q2 2025 137.66K $18.72M Reduce
Q3 2025 137.67K $18.44M Hold
Q4 2025 139.10K $17.43M Add
Q1 2026 140.10K $14.38M Add
Q2 2026 143.26K $13.00M Add
Q3 2026 147.47K $14.57M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has BAR HARBOR WEALTH MANAGEMENT held ABT?

BAR HARBOR WEALTH MANAGEMENT has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BAR HARBOR WEALTH MANAGEMENT's current position in ABT?

As of Q3 2026, BAR HARBOR WEALTH MANAGEMENT holds 147.47K shares of ABT (ABBOTT LABORATORIES), valued at $14.57M, representing 0.80% of its reported portfolio and ranking #29.

Has BAR HARBOR WEALTH MANAGEMENT been buying or selling ABT?

In the latest 13F filing (Q3 2026), BAR HARBOR WEALTH MANAGEMENT increased its position in ABT. The position peaked in Q2 2025 at 137.66K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.